This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Platelets, endothelium and arachidonic acid

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In platelets, arachidonic acid is converted by cyclo-oxygenases in prostaglandins G2 and H2 - PG2 and PGH2. Thromboxane synthetase converts these into thromboxane A2 - TXA2. TXA2 is a potent aggregator and vasoconstrictor.

However, in endothelial cells, PGH2 is instead converted to prostacyclin I2 - PGI2. PGI2 has exactly the opposite effects to TXA2.

The production of PGI2 may be one means of temporally and spatially limiting the extent of the thrombus. The balance between PGI2 and TXA2 may be involved in atherosclerosis and is the modulated by aspirin.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.